Co-Founder and ex-CEO of @AtaiBeckley NASDAQ : $ATAI. Passionate about building companies, mental health and biotech. Views are my own. No investment advice.
Joined November 2009
- Tweets 666
- Following 460
- Followers 3,539
- Likes 936
66 Photos and videos
Apr 18
This is so huge!! It cannot be emphasized enough what this policy paradigm shift means for people living with mental health conditions for whom available treatment options don’t work!
Congrats and an enormous amount of credit to @FutureJurvetson and @gjurvetson for spearheading this important policy initiative! Your grid and tenacity in advocating for this long overdue policy change is truly remarkable !
Apr 18
🏛️ Historic moment in the Oval Office just now for advancing psychedelic cures for the mental health crisis.
“The Prohibition on Psychedelics is now over.” — Bryan Hubbard
Funniest quip: “Ibogaine, can I get some?” — POTUS
With a chorus of support from leaders I photographed here, L to R: heads of NIDA, NIH, (Joe Rogan), HHS, White House Advisor Calley Means, FDA, and Genevieve who had been working on this for years.
Expect three accelerated programs for FDA approval next week, VA studies and Federal funding, and a hope for CMS reimbursement by end of year.
Full text: whitehouse.gov/presidential-…
3
1
37
1,863
Florian Brand retweeted
I am a strong believer in ibogaine, which is one of the reasons why @ataibeckley acquired the residual interest in its ibogaine program in Q4 2023 and now owns it 100%.
I’m very encouraged to see the administration taking a positive public stance on this important topic.
Ibogaine and other psychedelic therapies deserve greater attention - I believe they have the potential to improve the lives of millions.
And I believe $ATAI will lead this paradigm shift.
cbsnews.com/amp/news/psyched…
9
13
108
10,647
Mar 16
2/6 Why now?
Because this is no longer just an interesting scientific idea. It is becoming a real healthcare category.
The unmet need in mental health remains enormous, and the field is entering a critical phase.
2
2
4
321
Mar 16
5/6 But approvals alone will not be enough.
To bring this new model of care to patients at scale, especially in Europe, it will take an ecosystem: founders, scientists, clinicians, regulators, payors, care providers, and investors working together.
1
1
217
Mar 16
6/6
That is the real opportunity now.
Not just proving these treatments can work, but building the system that can deliver them responsibly and at scale to patients in need.
Looking forward to the conversation at @START_Global Summit on Friday.
1
201
Mar 16
1/6 Excited to join @START_Global this week in Switzerland for a fireside chat on the psychedelic medicine opportunity.
As co-founder and former CEO of one of the first psychedelics-focused biotechs, I’ve had a front-row seat to this field’s move from stigma to serious science, credible companies, and real clinical momentum.
$ATAI $CMPS $GHRS $DFTX
2
2
10
604
Florian Brand retweeted
Mar 10
Check out this incredible pilot study on smoking that was just published in JAMA.
Psilocybin-assisted therapy helped smokers quit at far higher rates than the nicotine patch.
At 6 months, participants receiving psilocybin had over 6X greater odds of prolonged abstinence.
Psychedelics may become one of our most powerful tools for treating addiction!
Just published: our RCT shows psilocybin (magic mushrooms) dramatically beats nicotine patch for quitting smoking using the same psychotherapy! A single psilocybin session showed 6x greater odds of staying quit. Biologically verified. In @JAMANetworkOpen Thread 🧵 #Psychedelics #QuitSmoking
3
6
60
27,790
Mar 10
1/ When @LarsWilde and I flagged increasing pharma interest in psychedelics as a very encouraging sign last year, some thought it was premature. Turns out it wasn’t. A thread 🧵
$ATAI $CMPS $DFTX $GHRS
3
21
69
6,050
Mar 10
11/ In our substack we also discussed which Big Pharma could become the second-mover after AbbVie, focusing on players with existing commercial-stage CNS franchises. Since then we heard at events in Boston and SF that Eli Lilly, which recently re-entered CNS, is showing interest also.
Links in reply below 👇
3
7
591